Fultium-D3: vitamin D3 capsules launched

Fultium-D3 capsules have been launched for the prevention and treatment of vitamin D deficiency and as an adjunct to the treatment of osteoporosis in patients with or at risk of vitamin D insufficiency.

Although colecalciferol is currently available in preparations in combination with calcium, Fultium-D3 is the first colecalciferol-only licensed preparation available in the UK
Although colecalciferol is currently available in preparations in combination with calcium, Fultium-D3 is the first colecalciferol-only licensed preparation available in the UK

Each capsule of Fultium-D3 contains colecalciferol 800IU, which is equivalent to 20 microgram vitamin D3.

Dosing

For patients with serum vitamin D levels <25nmol/l, the recommended dose is 1–4 capsules daily for up to 12 weeks.

For the prevention of vitamin D deficiency (including adults and the elderly with serum levels 25–50nmol/l and for long-term maintenance therapy), patients should take 1 or 2 capsules daily.

As an adjunct to specific therapy for osteoporosis, 1 capsule daily is appropriate.

Contraindications

Fultium-D3 is not recommended in children under 12 years of age and is contraindicated in patients with peanut or soya allergy.

View Fultium-D3 drug records

Further information: Internis Pharmaceuticals Ltd

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Gluten-free prescribing restricted to bread and mixes

Gluten-free prescribing restricted to bread and mixes

GPs in England are no longer able to prescribe gluten-free...

New vitamin D deficiency thresholds recommended

New vitamin D deficiency thresholds recommended

The National Osteoporosis Society (NOS) has updated...

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors may be linked to a doubling in the...

New MIMS table helps prescribers choose asthma inhalers

New MIMS table helps prescribers choose asthma inhalers

Prescribers can now turn to a handy MIMS comparison...